Click here for a PDF version of the program
Thursday, November 10, 2022
| Simultaneous Pre-Congress Workshops-Require separate registration and are not included in the general congress registration fees. Click here to register. | |||
| 13:30-17:00 Workshop A Cryopreservation of ovarian tissue: Hands-on lab and clinics; tissue collection; lab preparation and tissue slow-freezing; transplantation techniques Marie-Madeleine Dolmans, Belgium; Claus Yding Andersen, Denmark; Debra Gook, Australia; Jacques Donnez, Belgium; Linn Mamsen, Denmark; Luciana Cacciottola, Belgium Register here |
13:30-17:00 Workshop B Oocyte Vitrification**: The Theory and Practice of human oocyte vitrification; factors influencing the outcomes in human ART. Hands-on training with animal oocytes. Olga DeSilva, Denmark; Cornelia Meyer, Germany; Julie Jerumanis, Belgium; Aaron Lakmaker, Spain** Workshop can be attended only by participants who have experience in handling mammalian oocytes Sponsored by CooperSurgical  Register here |
15:00-17:00 National session- FertiPROTEKT- Fertility preservation: what else matters? Chairs: Kenny A. Rodriguez-Wallberg, Sweden Ralf Dittrich, Germany Register here |
14:00-18:00 National sessions – Asian Society for Fertility Preservation (ASFP) & The Fertility Preservation Society India (FPSI) President ASFP – Dr. Nalini Kaul – Mahajan Register here |
| 13:30-13:35 Welcome Marie-Madeleine Dolmans, Belgium13:35-14:35
14:35-17:00 |
13:30-13:35 Welcome Julie Jerumanis, Belgium13:35-14:30 Theory of vitrification and warming of oocytes Cornelia Meyer, Germany; Olga DeSilva, Denmark 14:30-17:00 ** Workshop can be attended only by participants who have experience in handling mammalian oocytes |
Before gonadotoxic therapy: Indications in different diseases Michael Von Wolff, SwitzerlandDuring gonadotoxic therapy: Heavy uterine bleeding – prevention and treatment Susanna Weidlinger, Switzerland After gonadotoxic therapy: Endocrinological care FertiPROTEKT –Data from the network |
14:00-14:10 Welcome Asian Society for Fertility Preservation (ASFP) Session Chairpersons: Dr. T.M. Chau Le, Dr. Padma Rekha Jirge14:15-14:30 Fertility Preservation in Developing Countries – how far have we come Dr. Virgilio M. Novero 14:30-14:50 14:50-15:00 15:00-15:15 15:15-16:15 The Fertility Preservation Society India (FPSI) Session 16:20-17:45 17:45-18:00 |
| 18:30 Welcome Reception Supported by Visit Brussels The welcome reception will be held in the Exhibition and Poster area, in the GALLERY. All registered participants are invited to attend. |
|||
Friday, November 11, 2022
| 09:00-09:05 | Welcome Marie-Madeleine Dolmans, President of ISFP |
| 09:05-09:20 | Congress retrospective: 15 years of ISFP Jacques Donnez, Belgium, Sam Kim, USA |
| 09:20-09:45 | Session 1: Opening lecture Chairs: Jacques Donnez, Belgium, Sam Kim, USA, Hamish Wallace, UK |
| 09:20-09:45 | Fertility preservation: the recent changes and expectations Marie- Madeleine Dolmans, Belgium |
| 09:45-10:45 |  Cancer patients: what should be the criteria for fertility preservation? Chairs: Herman Tournaye, Belgium, Sasmira Lalwani, USA Industry-supported symposium by Ferring |
| 09:45-10:15 | Cancer patients: are the Edinburgh criteria for fertility preservation still accurate? Richard Anderson, UK |
| 10:15-10:45 | Fertility preservation: what it is, what it is not and how best to do it Glenn Schattman, USA |
| 10:45-11:10 | Coffee Break |
| 11:10-12:50 | Session 2: Fertility preservation in benign gynecological diseases Chairs: Felice Petraglia, Italy, Bruno Salle, France |
| 11:10-11:30 | Adenomyosis, endometriosis, and fibroid-linked infertility: the mechanisms Felice Petraglia, Italy |
| 11:30-11:50 | How to protect/restore fertility in case of uterine fibroids and adenomyosis? Jacques Donnez, Belgium |
| 11:50-12:10 | How to preserve fertility in case of endometriosis? Ana Cobo, Spain |
| 12:10-12:30 | How to preserve fertility in Turner syndrome patients? Marie-Madeleine Dolmans, Belgium |
| 12:30-12:50 | Uterine transplantation: state of the art Tommaso Falcone, USA |
| 12:50-13:50 | Lunch Break |
| 13:50-15:30 | Session 3: Andrology Chairs: Herman Tournaye, Belgium, Nao Suzuki, Japan |
| 13:50-14:10 | Fertility preservation in boys: recent developments, challenges, and new insights Jan-Bernd Stukenborg, Sweden |
| 14:10-14:30 | Preservation of fertility in transgender people Pasquale Patrizio, USA |
| 14:30-14:50 | Fertility preservation in childhood cancer and prepubertal testicular tissue Rod Mitchell, UK |
| 14:50-15:10 | Spermatogonial stem cells: from research to clinical relevance Joachim Wistuba, Germany |
| 15:10-15:30 | Man-made human sperm: hope or hype Yoni Baert, Belgium |
| 15:30-15:50 | Coffee Break |
| 15:50-17:50 | Session 4: IVM and poor responders Chairs: Richard Anderson, USA, Michel De Vos, Belgium, Debra Gook, Australia |
| Part 1: IVM | |
| 15:50-16:10 | Do we have arguments in favor of IVM alone in terms of live birth rate? Michel De Vos, Belgium |
| 16:10-16:30 | A new frontier: developing human IVM based on oocytes obtained during fertility preservation procedures Claus Yding Andersen, Denmark |
| 16:30-16:50 | A critical review of IVM: where are we really? Kenny Rodriguez Wallberg, Sweden |
| Part 2: Poor responders | |
| 16:50-17:10 | Is IVA the solution? Review of the literature and questions Stine Gry Kristensen, Denmark |
| 17:10-17:30 | Rejuvenating the ovary by stem cell transplantation Antonio Pellicer, Italy |
| 17:30-17:50 | Rejuvenating the oocyte: is mitochondrial or nucleus transfer the solution Chii-Ruey Tzeng, Taiwan |
Saturday, November 12, 2022
| 08:00-09:15 | Session 5: Chemotherapy and ovaries Chairs: Claus Yding Andersen, Denmark, Michael Von Wolff, Germany, Nalini Kaul-Mahajan, India |
|
| 08:00-08:25 | Mechanisms of ovarian damage from chemotherapy: apoptosis and/or follicle activation? Dror Meirow, Israel |
|
| 08:25-08:55 | Is OTC after chemotherapy efficacious or contra-indicated? The French experience- Catherine Poirot, France The Israeli experience- Moran Shapira, Israel |
|
| 08:55-09:15 | How to counteract gonadatoxicity? Isabelle Demeestere, Belgium |
|
| 09:15-09:20 | Technical Break | |
| 09:20-10:20 |  Updates in cryopreservation strategies Chairman: Jacques Donnez, Belgium Industry-supported symposium by GEDEON RICHTER |
|
| 09:20-09:35 | Egg freezing in oncological patients Michel De Vos, Belgium |
|
| 09:35-09:50 | Egg freezing for social reasons or age-related fertility decline Elisa Gil, Spain |
|
| 09:50-10:05 | Ovarian tissue freezing to delay menopause Marie-Madeleine Dolmans, Belgium |
|
| 10:05-10:20 | Concluding remarks Jacques Donnez, Belgium |
|
| 10:20-10:40 | Coffee Break | |
| 10:40-11:40 | Session 6A: Six oral communication lectures (basic science) Chairs: Isabelle Demeestere, Belgium, Dror Meirow, Israel |
Session 6B: Six oral communication lectures (clinical science) Chairs: Hamish Wallace, UK, Chii-Ruey Tzeng, Taiwan |
| 10:40-10:50 | Human umbilical cord perivascular cells (hucpvc) reduce ovarian fibrosis and improve pregnancy rates in a mouse model of natural ovarian aging Andree Gauthier-Fisher, Canada |
A pilot trial on the outcomes of fertility sparing treatment of atypical endometrial hyperplasia Charissa Goh, Singapore |
| 10:50-11:00 | Importance of oxygen tension in human ovarian tissue in vitro culture Francisco Vitale, Belgium |
Follicular steroidogenesis in random start protocols for oocyte cryopreservation Francesca Filippi, Italy |
| 11:00-11:10 | In vitro angiogenic stimulation of human ovarian tissue with small extracellular vesicles Ana Sofia Pais, Portugal |
Does ovarian tissue cryopreservation before neoadjuvant chemotherapy in breast cancer patient impact the ovarian recovery? Christine Decanter, France |
| 11:10-11:20 | Novel anti-mullerian hormone receptor 2 binding peptide (amhr2bp) and its affinity to amh receptor 2 Laura Detti, USA |
Ovarian tissue transplantation (OTT) for leukemia survivors Hila Raanani, Israel |
| 11:20-11:30 | Targeting the akt/mtor pathways during ovarian tissue cryopreservation and transplantation with pharmacological inhibitors to preserve the primordial follicle reserve Jules Bindels, Belgium |
Reproductive outcomes following ovarian tissue grafting at a large tertiary level center Kate Stern, Australia |
| 11:30-11:40 | Z-scores for comparative analyses of follicular density in ovarian cortex among children and young adultsz-scores for comparative analyses of follicular density in ovarian cortex among children and young adults Jasmin Hassan, Sweden |
What are the pregnancy and live birth rates in ovarian tissue transplantation and what factors are associated with success rates? Data from 196 women from the FERTIPROTEKT network Laura Lotz, Germany |
| 11:40-13:00 | Session 7: Paving the way to the future Chairs: Michelle Nisolle, Belgium, Jacques Donnez, Belgium, Evelyn Telfer, UK |
|
| 11:40-12:00 | The gamete microenvironment in iatrogenic and physiologic ovarian aging Francesca Elizabeth Duncan, USA |
|
| 12:00-12:20 | How to improve revascularization of the ovarian transplants Luciana Cacciottola, Belgium |
|
| 12:20-12:40 | From primordial follicle to mature oocyte: are we ready? Evelyn Telfer, UK |
|
| 12:40-13:00 | Multiple facets of the ovarian ageing in mammals Francesca Klinger, Italy |
|
| 13:00-14:00 | Lunch Break | |
| 14:00-15:50 | Session 8: Fertility preservation in breast and pelvic cancers Chairs: Jean-Luc Squifflet, Belgium, Tommaso Falcone, USA/UK |
|
| Four oral communications, preselected for an award | ||
| 14:00-14:10 | Uterine volume is dramatically decreased after Childhood Hematopoietic Stem Cell Transplantation whatever the conditioning regimen. A case-control MRI study in a cohort of childhood acute leukemia survivors Blandine Courbiere, France |
|
| 14:10-14:20 | Apoptosis and autophagy as determinants of ovarian reserve decline from birth to reproductive age in women undergoing ovarian tissue cryopreservation Luciana Cacciottola, Belgium |
|
| 14:20-14:30 | Prior exposure to chemotherapy does not reduce the in-vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients Tal Imbar, Israel |
|
| 14:30-14:40 | Human platelet lysate improve the growth and survival of isolated human pre-antral follicles in vitro Cristina Subiran Adrados, Denmark |
|
| 14:40-15:30 | Keynote lecture: Conservative surgery in ovarian cancer, BOT and cervical cancer Catherine Uzan, France |
|
| 15:30-15:50 | Fertility preservation in women with breast cancer Michael Von Wolff, Germany |
|
| 15:50-16:15 | Closing remarks Marie-Madeleine Dolmans, Belgium |
|
| 16:15 | Award and closing ceremony | |
